300255 常山药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-2.911-14.789-50.9360.5727.896
总资产报酬率 ROA (%)-0.976-5.471-23.3290.3124.785
投入资产回报率 ROIC (%)-1.073-5.997-25.3300.3345.154

边际利润分析
销售毛利率 (%)15.91516.10322.50244.42158.181
营业利润率 (%)-8.026-24.645-86.9460.8758.827
息税前利润/营业总收入 (%)1.665-15.118-80.7374.81011.218
净利润/营业总收入 (%)-8.365-25.614-88.4940.4357.792

收益指标分析
经营活动净收益/利润总额(%)153.79184.07548.289164.29596.535
价值变动净收益/利润总额(%)-3.076-12.939-0.0010.0000.000
营业外收支净额/利润总额(%)-0.6211.1810.436-12.896-0.610

偿债能力分析
流动比率 (X)0.8710.9091.1852.1801.966
速动比率 (X)0.3080.2800.3290.8200.648
资产负债率 (%)68.25666.04460.84649.40240.805
带息债务/全部投入资本 (%)60.48659.45654.90444.55835.746
股东权益/带息债务 (%)59.85363.15079.332121.839176.804
股东权益/负债合计 (%)47.72452.30264.777102.558144.909
利息保障倍数 (X)0.173-1.539-12.2521.1924.590

营运能力分析
应收账款周转天数 (天)111.79580.28377.32453.40241.278
存货周转天数 (天)642.839630.661671.176653.827605.008